[1] |
郑荣寿, 孙可欣, 张思维, 等. 2015年中国恶性肿瘤流行情况分析[J]. 中华肿瘤杂志, 2019, 41(1): 19-28.
|
[2] |
Pinto JC, Pereira AD, Pimenta A, et al. Low rectal cancer treatment strategies: a cohort study assessing watch and wait[J]. Journal of Cancer Research and Clinical Oncology, 2020, 146(10): 2631-2638.
|
[3] |
Yamada K, Saiki Y, Takano S, et al. Long-term results of intersphincteric resection for low rectal cancer in Japan[J]. Surgery Today, 2019, 49(4): 275-285.
|
[4] |
Caycedo-marulanda A, Lee L, Chadi SA, et al. Association of transanal total mesorectal excision with local recurrence of rectal cancer[J]. JAMA Network Open, 2021, 4(2): e2036330.
|
[5] |
Khan SM, Emile SH, Barsom SH, et al. Development of the 'PREDICT' score through a systematic review and meta-analysis of the predictive parameters for locoregional recurrence after total mesorectal excision[J]. Updates in Surgery, 2021, 73(1): 35-46.
|
[6] |
Guinney J, Dienstmann R, Wang X, et al. The consensus molecular subtypes of colorectal cancer[J]. Nature Medicine, 2015, 21(11): 1350-1356.
|
[7] |
Lu W, Pan X, Dai S, et al. Identifying Stage Ⅱ colorectal cancer recurrence associated genes by microarray meta-analysis and building predictive models with machine learning algorithms[J]. Journal of Oncology, 2021, 2021(112): 1-13.
|
[8] |
Kamal Y, Dwan D, Hoehn HJ, et al. Tumor immune infiltration estimated from gene expression profiles predicts colorectal cancer relapse[J]. Oncoimmunology, 2021, 10(1): 1862529.
|
[9] |
Mei SW, Liu Z, Wei FZ, et al. Impact of interval between neoadjuvant chemoradiotherapy and surgery in rectal cancer patients[J]. World Journal of Gastroenterology, 2020, 26(31): 4624-4638.
|
[10] |
Hajibandeh S, Hajibandeh S, Eltair M, et al. Meta-analysis of transanal total mesorectal excision versus laparoscopic total mesorectal excision in management of rectal cancer[J]. International Journal of Colorectal Disease, 2020, 35(4): 575-593.
|
[11] |
Yao H, An Y, Zhang H, et al. Transanal Total Mesorectal Excision: Short-term Outcomes of 1283 Cases from a Nationwide Registry in China[J]. Diseases of the Colon and Rectum, 2021, 64(2): 190-199.
|
[12] |
Penna M, Hompes R, Arnold S, et al. Transanal total mesorectal excision: international registry results of the first 720 cases[J]. Annals of Surgery, 2017, 266(1): 111-117.
|
[13] |
Wasmuth HH, Faerden AE, Myklebust T, et al. Transanal total mesorectal excision for rectal cancer has been suspended in Norway[J]. The British Journal of Surgery, 2020, 107(1): 121-130.
|
[14] |
Fearnhead NS, Acheson AG, Brown SR, et al. The ACPGBI recommends pause for reflection on transanal total mesorectal excision[J]. Colorectal disease: the official journal of the Association of Coloproctology of Great Britain and Ireland, 2020, 22(7): 745-748.
|
[15] |
Penna M, Hompes R, Mackenzie H, et al. First international training and assessment consensus workshop on transanal total mesorectal excision (taTME)[J]. Techniques in Coloproctology, 2016, 20(6): 343-352.
|
[16] |
Van Oostendorp SE, Belgers HJ, Hol JC, et al. Learning curve of TaTME for rectal cancer is associated with local recurrence; results from a multicentre external audit[J]. Colorectal disease: the Official Journal of the Association of Coloproctology of Great Britain and Ireland, 2021, 23(8): 2020-2029.
|
[17] |
Kitz J, Fokas E, Beissbarth T, et al. Association of plane of total mesorectal excision with prognosis of rectal cancer: secondary analysis of the CAO/ARO/AIO-04 phase 3 randomized clinical trial[J]. JAMA Surgery, 2018, 153(8): e181607.
|
[18] |
Suzuki K, Dozois RR, Devine RM, et al. Curative reoperations for locally recurrent rectal cancer[J]. Diseases of the Colon & Rectum, 1996, 39(7): 730-736.
|
[19] |
Yamada K, Ishizawa T, Niwa K, et al. Patterns of pelvic invasion are prognostic in the treatment of locally recurrent rectal cancer[J]. The British Journal of Surgery, 2001, 88(7): 988-993.
|
[20] |
Boyle KM, Sagar PM, Chalmers AG, et al. Surgery for locally recurrent rectal cancer[J]. Diseases of the Colon and Rectum, 2005, 48(5): 929-937.
|
[21] |
Moore HG, Shoup M, Riedel E, et al. Colorectal cancer pelvic recurrences: determinants of resectability[J]. Diseases of the Colon and Rectum, 2004, 47(10): 1599-1606.
|
[22] |
Belli F, Sorrentino L, Gallino G, et al. A proposal of an updated classification for pelvic relapses of rectal cancer to guide surgical decision-making[J]. Journal of Surgical Oncology, 2020, 122(2): 350-359.
|
[23] |
Sorrentino L, Belli F, Guaglio M, et al. Prediction of R0/R+ surgery by different classifications for locally recurrent rectal cancer[J]. Updates in Surgery, 2021, 73(2): 539-545.
|
[24] |
Koh CE, Brown KGM, Steffens D, et al. What constitutes a clear margin in patients with locally recurrent rectal cancer undergoing pelvic exenteration?[J]. Annals of Surgery, 2020, Feb 14.
|
[25] |
Cyr DP, Zih FSW, Wells BJ, et al. Long-term outcomes following salvage surgery for locally recurrent rectal cancer: A 15-year follow-up study[J]. Ejso, 2020, 46(6): 1131-1137.
|
[26] |
Austin KK, Herd AJ, Solomon MJ, et al. Outcomes of pelvic exenteration with en bloc partial or complete pubic bone excision for locally advanced primary or recurrent pelvic cancer[J]. Diseases of the Colon and Rectum, 2016, 59(9): 831-835.
|
[27] |
Milne T, Solomon MJ, Lee P, et al. Assessing the impact of a sacral resection on morbidity and survival after extended radical surgery for locally recurrent rectal cancer[J]. Annals of Surgery, 2013, 258(6): 1007-1013.
|
[28] |
Dozois EJ, Privitera A, Holubar SD, et al. High sacrectomy for locally recurrent rectal cancer: Can long-term survival be achieved?[J]. Journal of Surgical Oncology, 2011, 103(2): 105-109.
|
[29] |
Brown KGM, Solomon MJ, Austin KKS, et al. Posterior high sacral segmental disconnection prior to anterior en bloc exenteration for recurrent rectal cancer[J]. Techniques in Coloproctology, 2016, 20(6): 401-404.
|
[30] |
Abdelsattar ZM, Mathis KL, Colibaseanu DT, et al. Surgery for locally advanced recurrent colorectal cancer involving the aortoiliac axis: can we achieve R0 resection and long-term survival?[J]. Diseases of the Colon and Rectum, 2013, 56(6): 711-716.
|
[31] |
Peacock O, Smith N, Waters PS, et al. Outcomes of extended radical resections for locally advanced and recurrent pelvic malignancy involving the aortoiliac axis[J]. Colorectal Disease: the Official Journal of the Association of Coloproctology of Great Britain and Ireland, 2020, 22(7): 818-823.
|
[32] |
Brown KGM, Solomon MJ, Lau YC, et al. Sciatic and femoral nerve resection during extended radical surgery for advanced pelvic tumours: long-term survival, functional, and quality-of-life outcomes[J]. Annals of Surgery, 2021, 273(5): 982-988.
|
[33] |
Uemura M, Ikeda M, Kawai K, et al. Laparoscopic surgery using a Gigli wire saw for locally recurrent rectal cancer with concomitant intraperitoneal sacrectomy[J]. Asian Journal of Endoscopic Surgery, 2018, 11(1): 83-86.
|
[34] |
Hasegawa S, Kajitani R, Matsumoto Y, et al. Combined laparoscopic and transperineal endoscopic total pelvic exenteration for local recurrence of rectal cancer[J]. Techniques in Coloproctology, 2020, 24(6): 599-601.
|
[35] |
Matsui H, Ichikawa N, Homma S, et al. Combined laparoscopic and transperineal endoscopic pelvic tumor resection with sacrectomy for locally recurrent rectal cancer[J]. Journal of the Anus, Rectum and Colon, 2021, 5(3): 327-333.
|